ALBANY, N.Y.--(BUSINESS WIRE)--AMRI (NASDAQ: AMRI) today reported financial and operating results for the second quarter ended June 30, 2011.
Financial highlights for the second quarter include:
- 18% growth in Development/Small Scale Manufacturing contract revenue over second quarter 2010
- 21% growth in Large Scale Manufacturing contract revenue over second quarter 2010
- Received $3 million milestone payment resulting from AMRI’s collaboration with Bristol-Myers Squibb (BMS) for the initiation of a phase II study
